Trials / Unknown
UnknownNCT01699477
Safety Study Using Transcranial MR Guided Focused Ultrasound in the Treatment of Neuropathic Pain
MR-Guided Functional Ultrasound-Neurosurgery
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- University Children's Hospital, Zurich · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to asses the efficacy and the clinical safety of the transcranial magnetic resonance guided high intensity focused ultrasound system ExAblate 4000, InSightec Ltd. for functional neurosurgery. The treatments to be conducted in this study are non-invasive, i.e. without opening the skull, and will create micro-thalamotomies in specific target areas such as thalamus, subthalamus and pallidum. The data obtained in this study will be used to evaluate the basic safety aspects of this new treatment technology and will serve as a basis for the clinical introduction of MR-guided ultrasound-neurosurgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ExAblate 4000 focused ultrasound brain intervention | Non-invasive brain intervention using MR-guided focused ultrasound |
Timeline
- Start date
- 2008-08-01
- Primary completion
- 2013-12-01
- Completion
- 2013-12-01
- First posted
- 2012-10-03
- Last updated
- 2012-10-03
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT01699477. Inclusion in this directory is not an endorsement.